|
|
| | L-Proline, L-leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl- Basic information |
| | L-Proline, L-leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl- Chemical Properties |
| Boiling point | 1113.1±65.0 °C(Predicted) | | density | 1.292±0.06 g/cm3(Predicted) | | pka | 3.40±0.20(Predicted) | | Sequence | Leu-Pro-Pro-Leu-Pro-Tyr-Pro |
| | L-Proline, L-leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl- Usage And Synthesis |
| Uses | IPL344 protects cells of various types from pro-apoptotic pressures and activates the Akt signaling system. IPL344 can be used for research of amyotrophic lateral sclerosis (ALS)[1][2]. | | References | [1] Eran Ovadia, et al. Peptide compounds and methods of treating diseases using same. Patent. WO 2021/144798 Al [2] Meglio M. Akt Activator IPL344 Demonstrates Safety, Signs of Efficacy in Phase 1/2 Study of ALS[J]. Neurology Times, 2022: NA-NA. |
| | L-Proline, L-leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl- Preparation Products And Raw materials |
|